LucidScope
AI is already answering questions about your brand. LucidScope shows you what it’s saying, and why.
LucidScope evaluates how leading AI systems respond to real-world questions about your company, products, indications, and competitors.
It maps visibility and positioning in AI-generated answers, traces the sources shaping those answers, and highlights gaps where evidence is missing, outdated, or misrepresented.
What you can do with LucidScope:
-
Perception Mapping: Compare how AI positions your brand versus key competitors.
- See how AI frames your brand versus competitors, by theme and attribute.
-
Answers Mapping: See how models answer the same stakeholder questions, and where they diverge.
- View side-by-side model answers to your key questions, with differences highlighted.
-
Source Tracing: Identify which websites and documents are shaping AI answers, and where to intervene.
- Understand which domains and documents drive the answers, and what’s missing.
-
Launch and campaign monitoring: Track changes over time across models, markets, and topics.
- Monitor shifts in positioning, key claims, and cited sources (you vs competitors).
Want to see what AI is saying about your brand? Request an AI Answer Audit.
You’ll receive a short report covering Perception, Answers, Source Tracing, and Zero-click gaps.
Already evaluating tools? Test LucidScope.
Questions or feedback? Email us anytime.
October 16, 2025
Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040
October 15, 2025
Lucid Diligence Brief: Verily UCHealth AI collaboration
October 15, 2025
Immunology Today: Zenas MS Deal, J&J FDA Approvals (Oct 8–15, 2025)
October 15, 2025
Top Neuroscience News: Video summary (Oct 1 –14, 2025)
October 15, 2025
Top Women’s Health News: Video summary (Oct 1 – Oct 14, 2025)
October 15, 2025
Lucid Diligence Brief: Kailera Therapeutics $600m Series B
October 14, 2025
Neuroscience Today: Roche & Lilly Lead in Alzheimer’s (Oct 7 –14, 2025)
October 14, 2025
Top Obesity News: Video summary (Sept 30 – Oct 14, 2025)
October 14, 2025
Obesity Today: Chugai licenses CT-388 for Japan, GLP-1 access news (Oct 7–14, 2025)
October 14, 2025
Endocrinology Today : SMOC1 impact on T2D and more breakthroughs (Oct 7–14, 2025)
October 14, 2025
Lucid Diligence Brief: Excellergy ECRIs, $70M investment
October 13, 2025